Axsome Therapeutics, Inc. (AXSM)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$206.68-0.80%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · AXSM
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | 776.6 | 638.5 | 385.7 | 270.6 | 0.0 | — | — | — | — | — | — |
| Total Revenues | — | — | — | — | 0.0 | — | — | — | — | — | — |
| Cost of Revenues | — | — | — | — | 5.2 | — | — | — | — | — | — |
| Operating Expenses & Income | |||||||||||
| Selling, General & Admin | 712.7 | 570.6 | 411.4 | 323.1 | 159.3 | 66.6 | 28.9 | — | — | — | — |
| R&D Expenses | 187.9 | 183.3 | 187.1 | 97.9 | 57.9 | 58.1 | 70.2 | 53.6 | 23.5 | 20.0 | 21.2 |
| Operating Income | (186.1) | (166.8) | (280.6) | (231.8) | (179.8) | (124.7) | (99.1) | (67.2) | (32.8) | (27.2) | (27.5) |
| Earnings from Continuing Operations | |||||||||||
| Interest Expense | (17.2) | (15.9) | (21.6) | (20.0) | (9.7) | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (191.1) | (183.7) | (287.1) | (238.3) | (187.1) | (130.4) | — | — | — | — | — |
| Income Tax Expense | — | (0.5) | 0.1 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | |||||||||||
| Net Income | (191.6) | (183.2) | (287.2) | (239.2) | (187.1) | (130.4) | (102.9) | (68.3) | (31.0) | (28.9) | (27.2) |
| Per Share | |||||||||||
| Basic EPS | (3.70) | (3.68) | (5.99) | (5.27) | (4.60) | (3.47) | (2.77) | — | — | — | — |
| Diluted EPS | (3.70) | (3.68) | (5.99) | (5.27) | (4.60) | (3.47) | (2.77) | — | — | — | — |
| Revenue per Share | 14.99 | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 51.8 | 49.7 | 47.9 | 45.4 | 40.7 | 37.6 | 37.2 | — | — | — | — |
| Diluted Weighted Avg Shares | 51.8 | 49.7 | 47.9 | 45.4 | 40.7 | 37.6 | 37.2 | — | — | — | — |
| Supplemental | |||||||||||
| EBIT | (186.1) | (166.8) | (280.6) | (231.8) | (179.8) | (124.7) | (99.1) | (67.2) | (32.8) | (27.2) | (27.5) |
| Effective Tax Rate | — | — | — | -0.4% | 0.0% | 0.0% | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.